Skip to main content
. 2020 May 14;13:1419–1428. doi: 10.2147/IDR.S249475

Table 2.

The Profile of Routine Antibacterial Resistance in P. aeruginosa

Strain MICs of Clinical Routine Antimicrobial Agents (μg/mL)
IPM MEM AMK CAZ CIP LVX TOB TZP FEP
TL-2856 a1 0.25 1 2 ≤0.125 0.25 0.5 8/4 2
b8 2 2 2 ≤0.125 0.5 0.5 4/4 2
TL-2862 a1 1 2 2 ≤0.125 0.5 0.5 4/4 1
b8 4 2 2 ≤0.125 0.5 0.5 4/4 2
TL-2870 a1 0.25 2 2 ≤0.125 0.25 1 4/4 1
b16 4 2 2 ≤0.125 0.25 1 4/4 2
TL-2872 a2 1 1 4 ≤0.125 0.5 1 8/4 4
b16 8 1 4 0.25 0.5 1 8/4 4
TL-2873 a2 1 2 2 ≤0.125 0.5 1 8/4 4
b8 4 2 2 ≤0.125 0.5 1 8/4 4
TL-2877 a2 0.25 2 2 ≤0.125 0.5 1 2/4 1
b16 4 4 2 ≤0.125 0.25 1 4/4 1
TL-2854 8 4 4 2 0.25 1 1 4/4 8
TL-2858 16 4 2 64 0.5 2 0.5 ≥128/4 32
TL-2859 16 4 8 2 1 1 32 4/4 8
TL-2878 16 4 2 64 0.5 1 0.5 ≥128/4 16
TL-2958 16 4 4 4 0.5 1 2 4/4 4
TL-2997 8 4 2 2 0.25 0.5 1 4/4 4
TL-2874 1 0.25 4 2 0.25 0.5 1 4/4 2
TL-2875 1 0.125 2 2 0.25 0.5 0.5 4/4 2
TL-2891 1 0.25 4 4 ≤0.125 0.5 1 4/4 2
TL-2892 1 ≤0.125 1 1 ≤0.125 0.25 0.5 2/4 1
TL-2907 1 0.125 4 2 ≤0.125 0.25 2 4/4 2
TL-2908 1 0.5 4 32 ≤0.125 0.25 1 128/4 2

Notes: aSusceptible population; bheteroresistant subpopulation; resistant and susceptible strains were shown in blue shading and gray shading, respectively.

Abbreviations: MEM, meropenem; AMK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; LVX, levofloxacin; TOB, tobramycin; TZP, piperacillin/tazobactam; FEP, cefepime.